GILD has been in the news 450% more than usual
Dec 08, 2025, 7:31 PM
1.78%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
GILD has been in the news recently: Gilead Sciences Inc's short interest has declined by 5.52% to 17.01 million shares, representing 1.37% of its float and requiring 2.32 days to cover. Additionally, Kymera Therapeutics, Inc. announced positive Phase 1b trial results for an oral treatment targeting atopic dermatitis, while Arcellx Inc. presented new data from its Phase 2 study on a therapy for multiple myeloma.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.